Article
Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation.
Molecular cancer therapeutics - 1 Aug 2004
Liu Liang, Berletch Joel B, Green Jessica G, Pate Mitchell S, Andrews Lucy G, Tollefsbol Trygve O
Abstract excerpt
Human promyelocytic leukemia HL60 cells display high telomerase activity, a phenotype related to their immortal status. All-trans retinoic acid (ATRA) is a clinically effective cytodifferentiating agent. To understand the mechanism underlying ATRA-induced cytodifferentiation, we did a kinetic analysis of the role of ATRA in inhibiting telomerase in HL60 cells. Our studies indicate that telomerase inhibition by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
